Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-EGFR&MET, JNJ-61186372 Vector   (CAT#: GTVCR-WQ1604MR)

This product GTVCR-WQ1604MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting EGFR&MET. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_001346897.2; NM_000245.4
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 1956; 4233
UniProt ID Q504U8; P08581
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-EGFR&MET, JNJ-61186372 Vector (GTVCR-WQ1604MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ2229MR IVTScrip™ pSP6-VEE-mRNA-Anti-TFPI, PF-06741086 Vector Vector PF-06741086
GTVCR-WQ2097MR IVTScrip™ pSP6-VEE-mRNA-Anti-PDCD1, NPVPDR001 Vector Vector NPVPDR001
GTVCR-WQ2560MR IVTScrip™ pT7-VEE-mRNA-Anti-TNF, TNFR55-Ig1 Vector Vector TNFR55-Ig1
GTVCR-WQ926MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL6, CDP 6038 Vector Vector CDP 6038
GTVCR-WQ1021MR IVTScrip™ pSP6-VEE-mRNA-Anti-CCL2, CNTO 888 Vector Vector CNTO 888
GTVCR-WQ2436MR IVTScrip™ pT7-VEE-mRNA-Anti-CD19, aCD1919 Vector Vector aCD1919
GTVCR-WQ844MR IVTScrip™ pSP6-VEE-mRNA-Anti-GP, c4G7-N Vector Vector c4G7-N
GTVCR-WQ1592MR IVTScrip™ pT7-VEE-mRNA-Anti-EGFR, J2898A Vector Vector J2898A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.